Evidence map›Paper›PMID 10921967›Full record

ArticleJournal of clinical microbiology2000

Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.

T Tollersrud, K Kenny, A J Reitz, J C Lee

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Within-Host Adaptation ofInternational journal of molecular sciences · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genotypic and phenotypic detection of capsular polysaccharides in Staphylococcus aureus isolated from bovine intramammary infections in Argentina.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Staphylococcus aureus capsular polysaccharides.Clinical microbiology reviews · 2004
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T TollersrudSection of Immunoprophylaxis, National Veterinary Institute, Oslo, Norway. tore.tollersrud@vetinst.no
K Kenny
A J Reitz
J C Lee

Funding

GENETIC ANALYSIS OF S AUREUS CAPSULE PRODUCTIONR01AI029040 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, JEAN CLAIRE · 1990 to 2005
$1.5M
GENETIC ANALYSIS OF S. AUREUS CAPSULE PRODUCTIONR21AI029040 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, JEAN CLAIRE · 2000 to 2000
$285k
NIAID NIH HHS AI29040NIAID NIH HHS R01 AI029040NIAID NIH HHS R21 AI029040
6 · The paper itself

Abstract

Bovine mastitis caused by Staphylococcus aureus is responsible for major economic losses to the dairy industry, and more-effective therapeutic or preventive approaches are sorely needed. The predominance of staphylococcal capsular polysaccharide types 5 and 8 among human isolates from many sources is well documented, but there seems to be a greater variation in the distribution of capsular serotypes among isolates from cows. A total of 636 isolates of S. aureus from cases of bovine mastitis in Sweden, Denmark, Finland, Iceland, Ireland, and the United States were investigated for production of capsular polysaccharide types 5 and 8. Approximately half of all the European isolates tested were of serotype 8, although variation among countries and among isolates of clinical and subclinical origin was observed. Sweden had the highest frequency (87%) of serotypeable isolates, and Finland had the lowest (48%). Capsule types 5 and 8 accounted for only 42% of the U.S. isolates tested. A few isolates showed weak reactivity with CP5 antiserum in a colony blot assay, and an enzyme-linked immunosorbent assay inhibition method confirmed that the levels of capsule produced by these strains were <10% of those produced by control strains. Fifty isolates that failed to react with capsular antisera all possessed the genes for production of capsular polysaccharide type 5 or 8. These results underscore the variability in capsule production by bovine isolates of S. aureus from different geographic regions. This information is important for the rational design of a capsule-based vaccine to prevent S. aureus bovine mastitis.

Indexed as

AnimalsAntibodies, BacterialBacterial CapsulesCattleEuropeFemaleHumansMammary Glands, AnimalMastitis, BovineNucleic Acid HybridizationSerotypingStaphylococcal InfectionsStaphylococcusStaphylococcus aureusUnited StatesAntibodies, Bacterial

Identifiers

PMID10921967
PMCPMC87170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.